🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wanqi Chen

Huazhong Agricultural University

ORCID: 0000-0001-5990-3691

Also affiliated with Chinese University of Hong Kong, Shenzhen, Jining Medical University

Physics and AstronomyMedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin.

5 citations

Lisi Zheng, Wanqi Chen, Xia Zhang, Dongming Lv, Cuiling Zeng +5 more

42 citations

Nishantha R. Bokka, Krishna Rao Maddipati, Srinivas Ayilavarapu, Robin Weltman, Lisha Zhu +6 more

0 citations

Chao Hsing Yeh, H.-N Wu, Xinran Huang, Wanqi Chen, Thomas J. Murphy +2 more

0 citations

Nada Lukkahatai, Wanqi Chen, Hulin Wu, Jennifer Kawi, Constance Johnson +3 more

0 citations

Hongyu Wang, Xinran Huang, Wanqi Chen, Hulin Wu, Jennifer Kawi +4 more